Pharma/Biotech General Discussion


What's the Strategy in the U.S. for Neovasc's Reducer?

8 months ago

Neovasc (Nasdaq: NVCN) is a medical device company primarily known for Reducer, which is a minimally invasive device that helps treat patients with refractory angina. The device has been approved in Europe

HTBX - Lets talk about tcells

3 weeks ago

Thoughts and opinion on immunotherapy and Heat Biologics tcells vaccines for covid and cancer...

What's the Strategy in the U.S. for Neovasc's Reducer?

8 months ago

Neovasc (Nasdaq: NVCN) is a medical device company primarily known for Reducer, which is a minimally invasive device that helps treat patients with refractory angina. The device has been approved in Europe

Osteoporosis Drugs Market Advancing due to Rising Disease Awareness

3 months ago

Osteoporosis, meaning porous bones, causes bones to become brittle and weak, which, in severe cases, can cause a fracture by even mild stress, such as that of sneezing, coughing, or bending over. The disease leads to deterioration of the bone tissue, low bone mass, and disruption of the bone microarchitecture. It is the most common bone-related disease in humans and represents a primary health concern. Osteoporosis is more common in women, Caucasians, and older people. Other than this, it affect…

Baker Brothers Advisors

7 months ago

They still lost so much money on the patent ruling. All the way from the 20's to $4 today after they lost.

Catalyst Biosciences

9 months ago

Catalyst Biosciences is a great company but why, why, why do they have to have a stock offering two days after I buy the stock? It's now down 17% which means I have to wait until the offering price is announced and then double my position in the company.

When's the next catalyst to get the stock back up?

PruGen Pharmaceuticals

9 months ago

Dermatologists hate Prugen and their business model. Prugen and PBMs are a HUGE reason why medications, especially generics, are so expensive. They are ultimately ripping off everyone from patients to insurance companies. Derms end up having to play games of prior authorizations and become a coupon clipper to help their patients get the meds they prescribe.

No wonder there have been significant layoffs at the company. Maybe people are finally waking up to the scam that Prugen really is.

Trump and Biotech

10 months ago

The thing is he kind of won. Stocks ended up hitting all-time highs again, Iran felt like they got revenge by hitting some bases with no one in them and he killed the guy he wanted to.

I personally think he wanted to bomb Iran back but he actually listened to smarter people this time around. For someone who can't stand the guy I was impressed. Still think killing Qasem Soleimani was a waste as they will just replace him with someone more awful as he was.

Google DeepMind Spots Breast Cancer Better Than Radiologists

10 months ago

Google’s DeepMind was recently able to beat radiologists in identifying cases of breast cancer. DeepMind used AI on 2D and 3D mammography images from ~30,000 women in the U.S. and the U.K, with DeepMind being able to identify people who had their cancer confirmed within the following year via a tissue biopsy or subsequent X-rays.

The article was published in Nature. The AI cut the number of people incorrectly referred for additional screening with a false positive by 5.7% and detecting 9.4% of …

Perceptive Advisors

10 months ago

I've heard about Perceptive Advisors Biotech hedge fund as being one of the best companies in the industry. Can anyone explain why they are so good and what companies they typically invest in?

I'm familiar with Baker Brothers and thought they were the best but I'm still new to this industry. Thanks in advance.

Loading...